Covered recipient · General Payments record
PATTI A ANOLIK
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2018–2024
$1,926.87
- Reported across 116 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $456.33 | 26 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $131.46 | 9 |
| Novo Nordisk AS | $118.59 | 6 |
| Acerta Pharma LLC | $68.87 | 4 |
| Lilly USA, LLC | $63.79 | 3 |
| Exact Sciences Corporation | $44.84 | 2 |
| PFIZER INC. | $14.69 | 1 |
| GlaxoSmithKline, LLC. | $14.09 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (26)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $17.65 | 01/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229173 | CMS |
| ABBVIE INC. | $9.34 | 01/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229175 | CMS |
| ABBVIE INC. | $5.68 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229177 | CMS |
| ABBVIE INC. | $14.96 | 04/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229179 | CMS |
| ABBVIE INC. | $19.31 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229181 | CMS |
| ABBVIE INC. | $19.68 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229183 | CMS |
| ABBVIE INC. | $18.07 | 08/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229185 | CMS |
| ABBVIE INC. | $12.07 | 10/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229187 | CMS |
| ABBVIE INC. | $14.70 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103229189 | CMS |
| AstraZeneca Pharmaceuticals LP | $13.34 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105475811 | CMS |
| AstraZeneca Pharmaceuticals LP | $21.14 | 10/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105497599 | CMS |
| AstraZeneca Pharmaceuticals LP | $19.43 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105576644 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.96 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105762042 | CMS |
| Exact Sciences Corporation | $22.64 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114577622 | CMS |
| Exact Sciences Corporation | $22.20 | 12/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114577625 | CMS |
| GlaxoSmithKline, LLC. | $14.09 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116473881 | CMS |
| Lilly USA, LLC | $21.84 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135265368 | CMS |
| Lilly USA, LLC | $22.76 | 01/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135280911 | CMS |
| Lilly USA, LLC | $19.19 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135310832 | CMS |
| Novo Nordisk Inc | $21.29 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097534406 | CMS |
| Novo Nordisk Inc | $21.36 | 02/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096696776 | CMS |
| Novo Nordisk Inc | $17.04 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097640041 | CMS |
| Novo Nordisk Inc | $17.58 | 07/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097324132 | CMS |
| Novo Nordisk Inc | $16.58 | 08/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096662283 | CMS |
| Novo Nordisk Inc | $24.74 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096928672 | CMS |
| PFIZER INC. | $14.69 | 09/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131956807 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.